emd 60263 has been researched along with gatifloxacin in 1 studies
| Studies (emd 60263) | Trials (emd 60263) | Recent Studies (post-2010) (emd 60263) | Studies (gatifloxacin) | Trials (gatifloxacin) | Recent Studies (post-2010) (gatifloxacin) |
|---|---|---|---|---|---|
| 12 | 0 | 1 | 1,047 | 131 | 268 |
| Protein | Taxonomy | emd 60263 (IC50) | gatifloxacin (IC50) |
|---|---|---|---|
| DNA gyrase subunit A | Escherichia coli K-12 | 0.5 | |
| DNA gyrase subunit B | Escherichia coli K-12 | 0.5 | |
| DNA topoisomerase 4 subunit A | Staphylococcus aureus | 1.2 | |
| DNA gyrase subunit A | Mycobacterium tuberculosis H37Rv | 9.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sen, S; Sinha, N | 1 |
1 other study(ies) available for emd 60263 and gatifloxacin
| Article | Year |
|---|---|
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |